Mfinanga, Godfrey Sayoki M

Title: MD, Post.Dip.Epid, PhD

Present position: Research Scientist –National Institute for Medical Research, Dar es Salaam, Tanzania
 

Institution where degree(s) were taken:
MD- University of Dar es Salaam (1991)
Postgraduate Diploma in Epidemiology/Biostatistics/Medical Informatics - Institute of Tropical Medicine, Antwerpen-Belgium (1996)
PhD- Centre for International Health, University of Bergen, Bergen, Norway (2004)
Previous research done in Haydom area (Title of thesis): Mycobacterial adenitis in Arusha, Tanzania: epidemiology and diagnostic challenges.

Current research or planned research in Haydom area or related to Haydom:
Future research will include diagnostic review of smear negative and extra-pulmonary tuberculosis (EPTB) and evaluate whether all EPTB diagnosed in the hospital needs anti-tuberculous drugs. More research will focus on HIV sero-prevalence in TB patients, KAPB among patients and community members, diagnostic delay both in patients in health system, and community based DOTS.

Contact information:
e-mail: gsmfinanga@yahoo.com; gsmfinanga@nimr.or.tz
Postal address:
National Institute for Medical Research
Muhimbili Medical Research Centre
P.O.Box 3436, Dar es Salaam, Tanzania

Publications:

  • Tehmina Mustafa, Harald G Wiker, Sayoki G M Mfinanga, Odd Mørkve, Lisbet Sviland. Immunohistochemistry using a Mycobacterium tuberculosis complex specific antibody for improved diagnosis of tuberculous lymphadenitis. Modern Pathology (2006) 19, 1606–1614. doi:10.1038/modpathol.3800697; published online 15 September 2006
  • Vegard Eldholm, Mecky Matee, Sayoki GM Mfinanga, Manfred Heun, and Ulf R Dahle. A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol. 2006; 6: 76. Published online 2006 September 13. doi: 10.1186/1471-2180-6-76.Copyright © 2006 Eldholm et al; licensee BioMed Central Ltd.
  • Tehmina Mustafa, Stanley J Mogga, Sayoki G M Mfinanga, Odd Mørkve, and Lisbet Sviland. Immunohistochemical analysis of cytokines and apoptosis in tuberculous lymphadenitis. Immunology. 2006 April; 117(4): 454–462. doi: 10.1111/j.1365-1567.2005.02318.x. Copyright © 2006 Blackwell Publishing Ltd
  • S. Cleaveland, D. Shaw, S. Mfinanga, G. Shirima, R. Kazwala, E. Eblate, M. Sharp. Mycobacterium bovis in rural Tanzania: Risk factors for infection in human and cattle populations.Tuberculosis (Edinb). 2007 Jan;87(1):30-43. Epub 2006 Apr 17.
  • Mustafa T, Mogga SJ, Mfinanga SG, Mørkve O, Sviland L. Immunohistochemical analysis of cytokines and apoptosis in tuberculous lymphadenitis. Immunology. 2006 Apr;117(4):454-62.
  • Mustafa T., Mogga S.J., Mfinanga S.G.M., Mørkve O., & Sviland L. (2005) Significance of Fas and Fas Ligand in Tuberculous, Lymphadenitis. Immunology 114, 255-262.
  • Mfinanga, S., Morkve, O., Sviland, L., Kazwala, R., Chande, H., & Nilson, R. (2005). Patient knowledge, practices and challenges to health care system in early diagnosis of mycobacterial adenitis. East African Medical Journal [Online], 82(4). pp173-180 Available: http://www.ajol.info/viewarticle.php?id=21578.
  • S.G.M. Mfinanga, O. Mørkve, R. R. Kazwala, S. Cleaveland, J. Kunda, M. J. Sharp, and R. Nilsen. Mycobacterial adenitis: role of mycobacterium bovis, non-tuberculous mycobacteria, HIV infection, and risk factors in Arusha, Tanzania. East African Medical Journal vol. 81 no. 4 April 2004 (in press)
  • Mfinanga, S., Morkve, O., Kazwala, R., Cleaveland, S., Sharp, M., Kunda, J., & Nilsen, R. (2004). Mycobacterial adenitis: role of Mycobacterium bovis, non-tuberculous mycobacteria, HIV infection, and risk factors in Arusha, Tanzania. East African Medical Journal [Online], 81(4). pp171-178 Available:http://www.ajol.info/viewarticle.php?id=15493.
  • Mfinanga, S. Mycobacterial Adenitis in Arusha, Tanzania: epidemiology and diagnostic challenges. [PhD thesis] Centre for International Health, University of Bergen, Bergen, Norway: 2003.
  • Mfinanga S.G, Morkve O,Kazwala R. R, Cleaveland S, Sharp J.M, Shirima G, Nilsen R. The role of livestock keeping in tuberculosis trends in Arusha, Tanzania. Int J Tuberc Lung Dis 2003; 7(7):695 – 704
  • Mfinanga S.G, Morkve O,.Kazwala R.R, Cleaveland S,.Sharp J. M, Shirima G, Nilsen R. Tribal difference in perception of tuberculosis: A possible role in tuberculosis control in Arusha, Tanzania. Int J Tuberc Lung Dis 2003; 7(10):933-941
  • Kunda J, Kilale A, Chonde TM, Mfinanga GS. Drug resistant tuberculosis; A potential threats to tuberculosis control programme- which way Tanzania. Tanzania Medical Journal, 2002; 17(1): 1-5
  • Range, N; Ipuge, Y A; O'Brien, R J; Egwaga, S M; Mfinanga, S G; Chonde, T M; Mukadi, Y D; Borgdorff, M W. Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998. Int J Tuberc Lung Dis 2001; 5( 5): 405-412.
  • Somi, G.R., O’Brien, R.J., Mfinanga, G.S., Ipuge, Y.A. Evaluation of theMycoDotTM test in patient with suspected tuberculosis in a field setting in Tanzania. Int J Tuberc Lung Dis 1999; 3(3): 231-238.
  • van den Broek, J., Mfinanga, S., Moshiro, C., O’Brien, R., Mugomela, A., Lefi, M. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania. Int J Tuberc Lung Dis 1998; 2(7): 547-552.
  • van den Broek J, Mfinanga S, Moshiro C, O'Brien R, Mugomela A. Survival of HIV-positive and HIV-negative leprosy patients in Mwanza, Tanzania. Int J Lepr Other Mycobact Dis. 1998 Mar;66(1):53-6.
  • Mfinanga,G.S., Kilale, A.M., Chonde, T.M., New Diagnostic Methods and their Place at Present in the Tuberculosis Problem in Developing Countries (Tanzania). Tanzania: Tanzania Medical Journal, March 1998; 13(1): 11 - 15.
  • Kilale, A.M., Mfinanga, G.S., Rugemalila, J.B., Somi, G.R. Current situation of tuberculosis in Tanzania. Tanzania Medical Journal, March 1998;13(1): 29-34.
  • Kilale, A.M., Mfinanga, G.S., Somi, G.R., Chonde, T.M., Kiogoloh, S. Effect of delayed processing of sputum specimens on laboratory results at the Central Tuberculosis Laboratory, Dar Es Salaam. Tanzania Medical Journal, March 1998; 13(1): 11 - 13.
  • Chonde TM, Kilale, AM, Mfinanga, GS, Mapalala, B.V. Problem in surveilance of anti-tuberculosis drug resistance in low-income country: Tanzania experience. Tanzania Medical Journal, March 1998; 13(1): 16 -18.

Work dissemination/ professional presentations:

  • Mfinanga GS. Mycobacterial adenitis in Arusha, Tanzania: epidemiology and diagnostic challenges. Lecture at PhD defence, 25.03.2004, University of Bergen, Norway
  • Mfinanga GS. Control of animal tuberculosis in the African setting: past, present and future. Lecture for PhD defence, 25.03.2004, University of Bergen, Norway
  • Attend a workshop in zoonotic diseases that was held from 6th to 9th February 2005, Nairobi Kenya
  • TB satellite meeting and presenter (Oral) of three papers during 20th Annual Joint Scientific Conference and Silver Jubilee Anniversary in March 1-4, 2005, Arusha
  • 34th World Conference on Lung Health of IUATLD, 29 October – 2 November 2003
  • Global Forum for Health Research, Forum 6, 12-15 November,2002, Arusha, Tanzania
  • 2nd Annual Students’ Scientific Conference of the Centre for International Health, University of Bergen, Norway
  • Seminars at University of Bergen, CIH (2001/2002)
  • 32nd International Union Against Tuberculosis and Lung Disease (IUATLD) World Conference on Lung Health, 1-4 November 2001, Paris-France
  • A workshop on Bovine Tuberculosis in Arusha, 4th December, 2000
  • Tanzania Veterinary Association, Scientific Conference in Arusha, 5-7, December 2000.
 

Løsningen er levert av Recommended | Driftes av Applica | Login